Research Paper Volume 16, Issue 9 pp 8361—8377
Comprehensive bioinformatics analytics and in vivo validation reveal SLC31A1 as an emerging diagnostic biomarker for acute myocardial infarction
Figure 6. Assessment of the infiltration of various immune cell types in both AMI and healthy control and their correlation with SLC31A1 expression. (A) Violin plot demonstrating the comparison of abundance of infiltrating immune cell types in the AMI group and healthy control. (B) Spearman correlation analysis between the SLC31A1 expression and diverse infiltrating immune cell types.